CAPTRUST Financial Advisors
RIGL icon

CAPTRUST Financial Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-108
Closed -$1K – 3624
2022
Q2 		$1K Sell
108
-6
-5% -$121 ﹤0.01% 4732
2022
Q1 		$3K Buy
114
+102
+850% +$2.76K ﹤0.01% 4385
2021
Q4 		$0 Sell
12
-35
-74% -$1.06K ﹤0.01% 4886
2021
Q3 		$2K Hold
47
– – ﹤0.01% 4294
2021
Q2 		$2K Hold
47
– – ﹤0.01% 4202
2021
Q1 		$2K Buy
+47
New +$1.86K ﹤0.01% 4070

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CAPTRUST Financial Advisors's RIGL Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Rigel Pharmaceuticals (RIGL) in Q3 2022, closing a stake of 108 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in RIGL in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q1 2022. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Rigel Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 108 Rigel Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Rigel Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Rigel Pharmaceuticals position peaked at $3K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.